ImmuPharma plc (LON:IMM – Get Free Report)’s share price was down 6.9% on Wednesday . The stock traded as low as GBX 4.50 ($0.06) and last traded at GBX 4.66 ($0.06). Approximately 4,119,310 shares traded hands during trading, a decline of 81% from the average daily volume of 22,171,900 shares. The stock had previously closed at GBX 5 ($0.06).
ImmuPharma Trading Up 22.1 %
The stock has a 50-day simple moving average of GBX 2.39 and a 200-day simple moving average of GBX 1.93. The company has a market cap of £19.82 million, a price-to-earnings ratio of -476.00 and a beta of 1.53.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Featured Articles
- Five stocks we like better than ImmuPharma
- What is an Earnings Surprise?
- Uber’s Business, Cash Flow, and AI are Why it Will Set a New High
- Consumer Staples Stocks, Explained
- Weak Guidance from Bristol-Myers Could Be Creating an Opportunity
- Following Congress Stock Trades
- These are the 3 Stocks Most Likely to Split in 2025
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
